Clinical Trial Update: Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 ) [NA]

View source ↗

Summary

Clinical trial update for a new 2.25mm specification of Firehawk in coronary heart disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Firehawk

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Heart Disease | NA | Status: COMPLETED | Results posted: 2020-02-20